T's Pharma

Privately held: no public share price · Japan

Assets

(2 total)
2Total Assets
0Approved
1Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
VogliboseNo recent activity
Phase 3
Alpha-glucosidaseSmall molecule
Type 2 Diabetes
Preclinical / Unstaged
Angiotensin II type 1 receptor / L-type calcium channelSmall molecule
Hypertension

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.